Mirion Technologies, Inc. Class A Common Stock (MIR)

Radiation safety company Mirion (NYSE:MIR) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 27.5% year on year to $257.6 mill...

Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced results for the first quarter ended March 31, 2026.

Mirion (MIR) Q3 2025 Earnings Transcript

Radiation safety company Mirion (NYSE:MIR) will be reporting earnings this Tuesday afternoon. Here’s what investors should know. Mirion missed analysts’ reve...

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...

Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou...

What Happened? A number of stocks fell in the afternoon session after geopolitical tensions in the Middle East intensified, pushing major indices into correc...

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expecta...

What Happened? A number of stocks jumped in the afternoon session after oil prices fell sharply following reports of de-escalating tensions between the U.S. ...

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic...

What a brutal six months it’s been for Mirion. The stock has dropped 22.5% and now trades at $19.06, rattling many shareholders. This was partly due to its s...

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs, reignited trade policy uncertainty. The move came swiftly after the Supreme Court ruled the previous week that the president could not use the International Emergency Economic Powers Act (IEEPA) for such duties, a decision that had initially sent markets higher. However, the administration invoked a different authority, the Trade Act of 1974, to impose a 15% global tariff for up to 150 days. The rapid reimposition of trade barriers creates significant uncertainty for companies across multiple sectors that depend on international supply chains and global trade. Investors are now weighing the potential impact of these new duties on corporate earnings and broader economic activity.

Mirion’s fourth-quarter results were met with a negative market reaction, reflecting missed revenue and non-GAAP EPS expectations. Management attributed the softer top-line to challenging comparisons in its labs and research and RTQA (Radiation Therapy Quality Assurance) segments, as well as delays in government-related orders due to a prolonged shutdown. CEO Thomas Logan explained that strong order growth in nuclear power and nuclear medicine helped offset these headwinds, with Logan noting, “We booked record orders in 2025 totaling more than $1 billion, largely driven by the nuclear power market.”

Mirion (NYSE: MIR) announced today that Chairman and Chief Executive Officer, Thomas Logan, and Chief Financial Officer and Medical Group President, Brian Schopfer, will present at Citi’s 2026 Global Industrial Tech and Mobility Conference. The presentation will begin at 2:40 PM ET on Wednesday, February 18, 2026.

Radiation safety company Mirion (NYSE:MIR) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 9.1% year on year to $277.4 million. Its non-GAAP profit of $0.15 per share was 7.8% below analysts’ consensus estimates.

Mirion (MIR) Q4 2025 Earnings Call Transcript

Mirion (NYSE: MIR), a global leader in radiation detection, measurement, analysis and monitoring solutions for the nuclear, medical, defense and research end markets, today announced three new leadership appointments supporting the company’s continued focus on safety, innovation, operational excellence and long-term growth.

Radiation safety company Mirion (NYSE:MIR) fell short of the market’s revenue expectations in Q4 CY2025, but sales rose 9.1% year on year to $277.4 million. Its non-GAAP profit of $0.15 per share was 7.8% below analysts’ consensus estimates.

Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets, today announced results for the fourth quarter and full year ended December 31, 2025.

Radiation safety company Mirion (NYSE:MIR) will be reporting earnings this Tuesday after market hours. Here’s what you need to know.